June 22, 2026 Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
June 22, 2026 Low-Value Marketing Assets Are Slowing Buyer Journeys and Raising Customer Acquisition Costs, Says Info-Tech Research Group
